Circulating microRNAs as biomarkers for evaluating the severity of acute spinal cord injury

Spinal Cord

Volumn 52, Issue 8, 2014, Pages 596-600

  Hachisuka, S ^a   Kamei, N ^a,b   Ujigo, S ^a   Miyaki, S ^b   Yasunaga, Y ^a   Ochi, M ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 146A 5P; MICRORNA 155; MICRORNA 219; MICRORNA 384 5P; MICRORNA 9; UNCLASSIFIED DRUG; MESSENGER RNA;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL MUSCULOSKELETAL DISEASE; FEMALE; GENETIC MARKER; LAMINECTOMY; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MOTOR ACTIVITY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; SPINAL CORD INJURIES; TIME;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION PROFILING; MICE; MICE, INBRED C57BL; MICRORNAS; MOTOR ACTIVITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SPINAL CORD INJURIES; TIME FACTORS;

EID: 84905590898     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2014.86     Document Type: Article

References (20)

1. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M et al. Administration of methylprednisolone for 24 or 48hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third national acute spinal cord injury randomized controlled trial. National Acute Spinal Cord Injury Study. JAMA 1997; 277: 1597-1604
2. Silva NA, Sousa N, Reis RL, Salgado AJ. From basics to clinical: A comprehensive review on spinal cord injury. Prog Neurobiol 2014; 114: 25-57
3. Yokobori S, Zhang Z, Moghieb A, Mondello S, Gajavelli S, Dietrich WD et al. Acute diagnostic biomarkers for spinal cord injury: Review of the literature and preliminary research report. World Neurosurg (e-pub ahead of print 19 March 2013; doi:10.1016/ j.wneu.2013.03.012
4. Chen X, Liang H, Zhang J, Zen K, Zhang CY. Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol 2012; 22: 125-132
5. Mo MH, Chen L, Fu Y, Wang W, Fu SW. Cell-free circulating miRNA biomarkers in cancer. J Cancer 2012; 3: 432-448
6. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-659
7. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso Mouse Scale for locomotion Detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006; 23: 635-659
8. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. Circulating microRNAs as stable blood-based markers for cancer detection. PNAS 2008; 105: 10513-10518
9. Roy S, Sen CK. MiRNA in innate immune responses: Novel players in wound inflammation. Physiol Genomics 2011; 43: 557-565
10. Hayakawa K, Okazaki R, Ishii K, Ueno T, Izawa N, Tanaka Y et al. Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study. Spinal Cord 2012; 50: 493-496
11. Loy DN, Sroufe AE, Pelt JL, Burke DA, Cao QL, Talbott JF et al. Serum biomarkers for experimental acute spinal cord injury: Rapid levation of neuron-specific enolase and S-100beta. Neurosurgery 2005; 56: 391-397
12. Ma J, Novikov LN, Karlsson K, Kellerth JO, Wiberg M. Plexus avulsion and spinal cord injury increase the serum concentration of S-100 protein: An experimental study in rats. Scand J Plast Reconstr Surg Hand Surg 2001; 35: 355-3591
13. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. New Engl J Med 1990; 322: 1405-1411
14. Wittmann J, Jack HM. Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta 2010; 1806: 200-207
15. Redell JB, Moore AN, Ward NH 3rd, Hergenroeder GW, Dash PK. Human traumatic brain injury alters plasma microRNA levels. J Neurotrauma 2010; 27: 2147-2156
16. Liu NK, Wang XF, Lu QB, Xu XM. Altered microRNA expression following traumatic spinal cord injury. Exp Neurol 2009; 219: 424-429
17. Nakanishi K, Nakasa T, Tanaka N, Ishikawa M, Yamada K, Yamasaki K et al. Responses of microRNAs 124a and 223 following spinal cord injury in mice. Spinal Cord 2010; 48: 192-196
18. Li JS, Yao ZX. MicroRNAs: Novel regulators of oligodendrocyte differentiation and potential therapeutic targets in Demyelination-related diseases. Mol Neurobiol 2012; 45: 200-212
19. Lau P, Verrier JD, Nielsen JA, Johnson KR, Notterpek L, Hudson LD. Identification of dynamically regulated microRNA and mRNA networks in Developing oligodendrocytes. J Neurosci 2008; 28: 11720-11730
20. Shin D, Shin JY, McManus MT, Ptácek LJ, Fu YH. Dicer ablation in oligodendrocytes provokes neuronal impairment in mice. Ann Neurol 2009; 66: 843-857